December 16, 2013 / 12:55 PM / in 4 years

BRIEF-BioLine Rx U.S.-listed shares up 20.4 percent premarket

NEW YORK, Dec 16 (Reuters) - BioLine RX Ltd : * U.S.-listed shares up 20.4 percent to $3.07 in premarket after initial phase 2 results of acute myeloid leukemia treatment

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below